Logo image of MLSS

MILESTONE SCIENTIFIC INC (MLSS) Stock Price, Forecast & Analysis

USA - NYSE Arca - NYSEARCA:MLSS - US59935P2092 - Common Stock

0.304 USD
0 (-0.56%)
Last: 11/21/2025, 8:04:00 PM
0.2903 USD
-0.01 (-4.51%)
After Hours: 11/21/2025, 8:04:00 PM

MLSS Key Statistics, Chart & Performance

Key Statistics
Market Cap23.88M
Revenue(TTM)8.63M
Net Income(TTM)-6.97M
Shares78.56M
Float61.85M
52 Week High1.39
52 Week Low0.28
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.08
PEN/A
Fwd PEN/A
Earnings (Next)04-13 2026-04-13/bmo
IPO1995-11-03
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


MLSS short term performance overview.The bars show the price performance of MLSS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

MLSS long term performance overview.The bars show the price performance of MLSS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of MLSS is 0.304 USD. In the past month the price decreased by -25.6%. In the past year, price decreased by -60.72%.

MILESTONE SCIENTIFIC INC / MLSS Daily stock chart

MLSS Latest News, Press Relases and Analysis

MLSS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.67 222.97B
ISRG INTUITIVE SURGICAL INC 65.23 201.33B
BSX BOSTON SCIENTIFIC CORP 32.84 143.55B
SYK STRYKER CORP 27.96 140.79B
IDXX IDEXX LABORATORIES INC 57.57 58.07B
BDX BECTON DICKINSON AND CO 13.36 55.24B
EW EDWARDS LIFESCIENCES CORP 33.12 49.98B
RMD RESMED INC 25.33 36.59B
GEHC GE HEALTHCARE TECHNOLOGY 16.66 34.90B
DXCM DEXCOM INC 32.38 23.62B
PODD INSULET CORP 72.47 23.31B
ZBH ZIMMER BIOMET HOLDINGS INC 11.39 18.26B

About MLSS

Company Profile

MLSS logo image Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

Company Info

MILESTONE SCIENTIFIC INC

220 S Orange Ave

Livingston NEW JERSEY 07068 US

CEO: Leonard Osser

Employees: 17

MLSS Company Website

MLSS Investor Relations

Phone: 19735352717

MILESTONE SCIENTIFIC INC / MLSS FAQ

Can you describe the business of MILESTONE SCIENTIFIC INC?

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.


What is the current price of MLSS stock?

The current stock price of MLSS is 0.304 USD. The price decreased by -0.56% in the last trading session.


Does MLSS stock pay dividends?

MLSS does not pay a dividend.


What is the ChartMill rating of MILESTONE SCIENTIFIC INC stock?

MLSS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is MLSS stock listed?

MLSS stock is listed on the NYSE Arca exchange.


How is the valuation of MILESTONE SCIENTIFIC INC (MLSS) based on its PE ratio?

MILESTONE SCIENTIFIC INC (MLSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).


What is the Short Interest ratio of MILESTONE SCIENTIFIC INC (MLSS) stock?

The outstanding short interest for MILESTONE SCIENTIFIC INC (MLSS) is 0.25% of its float.


MLSS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MLSS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MLSS. MLSS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MLSS Financial Highlights

Over the last trailing twelve months MLSS reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 37.92% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -86.63%
ROE -208.8%
Debt/Equity 0.25
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%-6.11%
EPS 1Y (TTM)37.92%
Revenue 1Y (TTM)-12.19%

MLSS Forecast & Estimates

8 analysts have analysed MLSS and the average price target is 2.04 USD. This implies a price increase of 571.05% is expected in the next year compared to the current price of 0.304.

For the next year, analysts expect an EPS growth of 20.67% and a revenue growth 6.02% for MLSS


Analysts
Analysts82.5
Price Target2.04 (571.05%)
EPS Next Y20.67%
Revenue Next Year6.02%

MLSS Ownership

Ownership
Inst Owners5.95%
Ins Owners6.14%
Short Float %0.25%
Short Ratio0.12